Crossmark

Correction: The clinical journey of belantamab mafodotin in relapsed or refractory multiple myeloma: lessons in drug development

Crossref DOI link: https://doi.org/10.1038/s41408-025-01243-7

Published Online: 2025-03-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mukhopadhyay, Pralay

Abdullah, Hesham A.

Opalinska, Joanna B.

Paka, Prani

Richards, Eric

Weisel, Katja https://orcid.org/0000-0001-9422-6614
Trudel, Suzanne

Mateos, Maria-Victoria https://orcid.org/0000-0003-2390-1218
Dimopoulos, Meletios Athanasios https://orcid.org/0000-0001-8990-3254
Lonial, Sagar https://orcid.org/0000-0002-8322-9323
License Information

Text and Data Mining valid from 2025-03-26

Version of Record valid from 2025-03-26
More Information

Article History

First Online: 26 March 2025